ACT Therapeutics Overview
- Year Founded
-
2020
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
ACT Therapeutics General Information
Description
Developer of a receptor cell therapy designed to target cancer antigens into immune cells. The company offers therapy that targets existing solid cancer by overcoming the immune suppression microenvironment and activating surrounding cells, enabling healthcare firms with a possible cure for cancer.
Contact Information
Website
www.actthera.comCorporate Office
- 5th Floor, Business Building
- 225-15, Pangyoyeok-ro, Bundang-gu
- Seongnam, Gyeonggi 13494
- South Korea
Corporate Office
- 5th Floor, Business Building
- 225-15, Pangyoyeok-ro, Bundang-gu
- Seongnam, Gyeonggi 13494
- South Korea
ACT Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 24-Jun-2024 | Completed | Out of Business | |||
| 3. Early Stage VC (Series A) | 12-Jul-2022 | Cancelled | Startup | |||
| 2. Early Stage VC | 12-Jul-2022 | Completed | Startup | |||
| 1. Seed Round | 01-Jan-2021 | Completed | Startup |
ACT Therapeutics FAQs
-
When was ACT Therapeutics founded?
ACT Therapeutics was founded in 2020.
-
Where is ACT Therapeutics headquartered?
ACT Therapeutics is headquartered in Seongnam, South Korea.
-
What industry is ACT Therapeutics in?
ACT Therapeutics’s primary industry is Drug Discovery.
-
Is ACT Therapeutics a private or public company?
ACT Therapeutics is a Private company.
-
What is ACT Therapeutics’s current revenue?
The current revenue for ACT Therapeutics is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process